Natalia V Naryzhnaya

16PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersCancer cell biologyAutoimmunityNanotoxicology, health and safetyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Dec 07, 2025
Metabolic syndrome reduces but does not eliminate the cardioprotective effect of adaptation to hypoxia: the link with changes in the opioid system.

Natalia V Naryzhnaya, Ivan A Derkachev, Boris K Kurbatov

|Oct 16, 2025
Associations Between Regulatory Immune Cells, Thymus Cellular Remodeling, and Vascular Aging in Advanced Coronary Atherosclerosis: A Pilot Study.

Irina Kologrivova, Alexey Dmitriukov, Natalia Naryzhnaya

|Jul 27, 2024
Thymus in Cardiometabolic Impairments and Atherosclerosis: Not a Silent Player?

Irina V Kologrivova, Natalia V Naryzhnaya, Tatiana E Suslova

|Jul 03, 2024
The β2-adrenergic receptor agonist formoterol attenuates necrosis and apoptosis in the rat myocardium under experimental stress-induced cardiac injury.

Natalia V Naryzhnaya, Sergey V Logvinov, Boris K Kurbatov

|May 11, 2024
Peptides Are Cardioprotective Drugs of the Future: The Receptor and Signaling Mechanisms of the Cardioprotective Effect of Glucagon-like Peptide-1 Receptor Agonists.

Alla A Boshchenko, Leonid N Maslov, Alexander V Mukhomedzyanov

Pageof 3